rifampin
- Product NDC
- 68180-658
- 11-digit product format
- 681800658
- Labeler code
- 68180
- Product ID
- 68180-658_5ed1edac-e11e-4f87-b390-e770a69a9b37
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifampin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA090034
- Marketing category
- ANDA
- Marketing start
- 2014-01-08
- Substance
- RIFAMPIN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- rifampin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFAMPIN | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VJT6J7R4TR |
| Rxcui | 198201, 198202 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-658-01 | rifampin | 60 in 1 BOTTLE | CAPSULE | 60 | | 26 |
| 68180-658-06 | rifampin | 30 in 1 BOTTLE | CAPSULE | 30 | | 26 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| RIFAMPIN | ACTIVE INGREDIENT | VJT6J7R4TR | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| RIFAMPIN | ACTIVE MOIETY | VJT6J7R4TR | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| STARCH, PREGELATINIZED CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-658 | RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 22 | Current NDC, Legacy NDC, 2 package rows | 20250221_b56004f0-f23d-47f6-80c7-39884fccbccc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-658-01 | 68180065801 | 60 CAPSULE in 1 BOTTLE (68180-658-01) | 60 capsule | 2014-01-08 | 0000-00-00 | No | No | Current |
| 68180-658-06 | 68180065806 | 30 CAPSULE in 1 BOTTLE (68180-658-06) | 30 capsule | 2014-01-08 | 0000-00-00 | No | No | Current |